The Greater Cannabis Company, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-25.00%)
Aug 1, 2025, 3:06 PM EDT
bluebird bio Market Cap
GCAN has a market cap or net worth of $202.48 thousand as of August 1, 2025. Its market cap has decreased by -64.05% in one year.
Market Cap
202.48K
Enterprise Value
536.74K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 18, 2018, GCAN's market cap has decreased from 4.11M to 202.48K, a decrease of -95.08%. That is a compound annual growth rate of -35.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 202.48K | -37.09% |
| Dec 31, 2024 | 321.86K | -51.31% |
| Dec 29, 2023 | 661.03K | 64.05% |
| Dec 30, 2022 | 402.95K | -74.44% |
| Dec 31, 2021 | 1.58M | 13.07% |
| Dec 31, 2020 | 1.39M | 13.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |